Abstract
Serotonin has been implicated in normal brain activities, and alterations in serotonin metabolism or serotonin receptors have been linked to disorders such as depression and schizophrenia (Fuller, 1986).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Appel, J.B., and Freedman, D.X., 1968, Tolerance and cross-tolerance among psychotomimetic drugs, Psychopharmacologia, 13: 267–274.
Biegon, A., Weizman, A., Karp, L., Ram, A., Tiano, S., and Wolff, M., 1987, Serotonin 5-HT2 receptor binding on blood platelets — a peripheral marker for depression? Life Sci., 41: 2485–2492.
Bradford, M.M., 1976, A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein dye binding, Anal. Biochem., 72: 248–254.
Buckholtz, N.S., Freedman, D.X., and Middaugh, L.D., 1985, Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain, Eur. J. Pharmacol., 109: 421–425.
Carey, R.G., and Neal, T.L., 1986, The rat claustrum: afferent and efferent connections with visual cortex, Brain Res., 329: 185–193.
Fuller, R.W., 1986, Pharmacologic modification of serotonergic function: Drugs for the study and treatment of psychiatric and other disorders, J. Clin. Psych., 47: 4–8.
Geaney, D.P., Schachter, M., Elliott, J.M., and Grahame-Smith, D.G., 1984, Characterization of [3H]-lysergic acid diethylamide binding to a 5-hydro-xytryptamine receptor on human platelet membranes, Eur. J. Pharmacol., 97: 87–93.
Glennon, R.A., McKenney, J.D., Lyon, R.A., and Titeler, M., 1986, 5HT1 and 5HT2 binding characteristics of l-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues, J. Med. Chem., 29: 194–199.
Glennon, R.A., Seggel, M.R., Soine, W.H., Herrick-Davis, K., Lyon, R.A., and Titeler, M., 1988, [125I]-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane: an iodinated radioligand that specifically labels the agonist high-affinity state of 5HT2 serotonin receptors, J. Med. Chem., 31: 5–7.
Israel, A., Correa, F.M.A., Niwa, M., and Saavedra, J.M., 1984, Quantitative determination of angiotensin II binding sites in rat brain and pituitary gland by autoradiography, Brain Res., 322: 341–345.
Jacobs, B.L., 1987, How hallucinogenic drugs work, Am. Sci., 75: 386–392.
Johnson, M.P., Hoffman, A.J., Nichols, D.E., and Mathis, C.A., 1987, Binding to the serotonin 5HT2 receptor by the enantiomers of [125I]-DOI, Neuropharmacology, 26: 1803–1806.
Mann, J.J., Stanley, M., McBride, A., and McEwen, B., 1986, Increased serotonin2 and β-adrenergic receptor binding in the frontal cortices of suicide victims, Arch. Gen. Psych., 43: 954–959.
McBride, P.A., Mann, J.J., Polley, M.J., Wiley, A.J., and Sweeney, J.A., 1987, Assessment of binding indices and physiological responsiveness of the 5-HT2 receptor on human platelets, Life Sci., 40: 1799–1809.
McKenna, D.J., Mathis, C.A., Shulgin, A.T., Sargent, T., 3rd, and Saavedra, J.M., 1987, Autoradiographic localization of binding sites for [125I]-DOI, a new psychotomimetic radioligand, in the rat brain, Eur. J. Pharmacol., 137: 289–290.
McKenna, D.J., Nazarali, A.J., Himeno, A., and Saavedra, J.M., 1989a, Chronic treatment with (±)DOI, a psychotomimetic 5-HT2 agonist, down-regulates 5-HT2 receptors in rat brain, Neuropsychopharmacology, 2: 81–87.
McKenna, D.J., Nazarali, A.J., Hoffman, A.J., Nichols, D.E., Mathis, C.A., and Saavedra, J.M., 1989b, Common receptors for hallucinogens in rat brain: a comparative autoradiographic study using [125I]-LSD and [125I]-DOI, a new psychotomimetic radioligand, Brain Res., 476: 45–56.
McKenna, D.J.., and Saavedra, J.M., 1987, Autoradiography of LSD and 2,5-dimethoxyphenylisopropylamine psychotomimetics demonstrates regional, specific cross-displacement in the rat brain, Eur. J. Pharmacol., 142: 313–315.
Miller, J.A., Curella, P., and Zahniser, N.R., 1988, A new densitometric procedure to measure protein levels in tissue slices used in quantitative autoradiography, Brain Res., 447: 60–66.
Nichols, D.E., Barfnecht, C.F., Rusterholz, D.B., Benington, F., and Morin, R.D., 1973, Asymmetric systhesis of psychotomimetic phenylisoproylamines, J. Med. Chem., 16: 480–483.
Pazos, A., Cortes, A., and Palacios, J.M., 1985, Quantitative autoradiographic mapping of serotonin receptors in the rat brain, II. Serotonin-2 receptors, Brain Res., 346: 231–249.
Pierce, P.A., and Peroutka, S.J., 1988, Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide, J. Pharmacol. Exp. Ther., 247: 918–925.
Scott, J.A., and Crews, F.T., 1986, Down-regulation of serotonin2 but not of beta-adrenergic receptors during chronic treatment with amitriptyline is independent of stimulation of serotonin2 or beta-adrenergic receptors, Neuropharmacology, 25: 1301–1306.
Shulgin, A.T., 1982, Chemistry of Psychotomimetics, in: “Handbook of Experimental Pharmacology”, Vol. 55, Part III, Alcohol and Psychotomimetics, Psychotropic Effects of Central Acting Drugs, Hoffmeister, F., and Stille, G., eds., Springer-Verlag, Berlin, pp. 3–29.
Wilhite, B.L., Teyler, T.J., and Hendricks, C., 1986, Functional relations of the rodent claustral-entorhinal-hippocampal system, Brain Res., 365: 54–60.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Saavedra, J.M., Himeno, A. (1991). Autoradiographic Studies of 5HT2 Receptors. In: Schwarcz, R., Young, S.N., Brown, R.R. (eds) Kynurenine and Serotonin Pathways. Advances in Experimental Medicine and Biology, vol 294. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5952-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5952-4_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5954-8
Online ISBN: 978-1-4684-5952-4
eBook Packages: Springer Book Archive